SUBSTANCE-P INDUCES DEGRANULATION OF MAST-CELLS AND LEUKOCYTE ADHESION TO VENULAR ENDOTHELIUM

被引:51
作者
SUZUKI, H [1 ]
MIURA, S [1 ]
LIU, YY [1 ]
TSUCHIYA, M [1 ]
ISHII, H [1 ]
机构
[1] KEIO UNIV, SCH MED, DEPT INTERNAL MED, SHINJUKU KU, TOKYO 160, JAPAN
关键词
MICROCIRCULATION; TOLUIDINE BLUE; CALCIUM; FURA-2; TRANILAST;
D O I
10.1016/0196-9781(95)02050-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Substance P (SP), one of the established neurotransmitters, evokes an immunoinflammatory response involving leukocyte adhesion to venular endothelium and the degranulation of mast cells. The pathogenetic relationship between these responses, however, remains unresolved. In this study, we propose to examine the changes associated with the activation of mast cells, as well as leukocyte adhesion to venular endothelium by in vivo observation of the rat mesentery. The use of an in vitro assay for intracellular Ca2+ mobilization and the degranulation of mast cells demonstrated the significant upper shift of concentration response to SP (10(-4)-10(-5) M). In vivo experiments on the mesenteric microcirculation also showed that SP induced a significant increase in the number of degranulated mast cells as well as in the number of leukocytes adherent to the venular wall. Tranilast, a mast cell stabilizer, as well as SP antagonist (CP-96,345) significantly attenuated the extent of mast cell degranulation and leukocyte adhesion elicited by SP. Although an immunoneutralization against CD18 by WT-3 significantly attenuated the leukocyte adhesion, it had no influence on the mast cell degranulation after SP superfusion. These separate in vivo observations show that SP induces leukocyte adhesion to the venular endothelium, possibly through the degranulation of mast cells.
引用
收藏
页码:1447 / 1452
页数:6
相关论文
共 43 条
[11]  
JANSCO N, 1967, BRIT J PHARMACOL, V31, P138
[12]  
JOHNSON AR, 1973, P SOC EXP BIOL MED, V142, P1252
[13]   STUDY OF CHEMICALLY-INDUCED ACUTE-INFLAMMATION IN SKIN OF RAT [J].
KIERNAN, JA .
QUARTERLY JOURNAL OF EXPERIMENTAL PHYSIOLOGY AND COGNATE MEDICAL SCIENCES, 1977, 62 (02) :151-161
[14]  
KIERNAN JA, 1972, Q J EXP PHYSL, V857, P311
[15]  
KROTZER JL, 1971, IMMUNOLOGY, V20, P545
[16]  
LAWRENCE ID, 1987, J IMMUNOL, V139, P3062
[17]  
LEMBECK F, 1979, N-S ARCH PHARMACOL, V310, P175, DOI 10.1007/BF00500282
[18]  
Liu Yu Ying, 1992, Keio Journal of Medicine, V41, P128
[19]   THE DISCOVERY OF (2S,3S)-CIS-2-(DIPHENYLMETHYL)-N-[(2-METHOXYPHENYL)METHYL]-1-AZABICYCLO[2.2.2]OCTAN-3-AMINE AS A NOVEL, NONPEPTIDE SUBSTANCE-P ANTAGONIST [J].
LOWE, JA ;
DROZDA, SE ;
SNIDER, RM ;
LONGO, KP ;
ZORN, SH ;
MORRONE, J ;
JACKSON, ER ;
MCLEAN, S ;
BRYCE, DK ;
BORDNER, J ;
NAGAHISA, A ;
KANAI, Y ;
SUGA, O ;
TSUCHIYA, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (14) :2591-2600
[20]   SUBSTANCE-P INDUCES THE EXPRESSION OF AN ENDOTHELIAL-LEUKOCYTE ADHESION MOLECULE BY MICROVASCULAR ENDOTHELIUM [J].
MATIS, WL ;
LAVKER, RM ;
MURPHY, GF .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 94 (04) :492-495